| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 08/22/2002 | US20020115628 Modulating the ability of a cell to affect the glycosylation state of a target selected from a lipid and a polypeptide by modulating the activity of an enzyme of either 47169 or 33935 protein; cell signaling; differentiation; tumorigenesis |
| 08/22/2002 | US20020115627 Phosphatonin-related gene and methods of use thereof |
| 08/22/2002 | US20020115626 Comparing the expression of the nucleic acid encoding an antileuko-protease polypeptide of a cell population to the expression of a nucleic acid encoding the same peptide in an inflammation positive reference profile; enzyme inhibitors |
| 08/22/2002 | US20020115616 Inhibit beta-secretase to reduce beta amyloid peptide concentrations and reduce the amyloid plaques and neuro-fibrillary tangles; Alzheimer's disease; stroke; Down' syndrome; amyotrophic lateral sclerosis; brain disorders |
| 08/22/2002 | US20020115615 A peptide compound, where a residue of the peptide compound corresponding to the amino acid at position 6 of natural mammalian LHRH is replaced; anticarcinogenic and -tumor agents; hormone inhibitors; urogenital disorders |
| 08/22/2002 | US20020115613 Treatment of prostate cancer |
| 08/22/2002 | US20020115612 High-speed automated solid-phase synthesis repeating steps of acylation of a resin-bound secondary amine with haloacetic acid followed by nucleophilic displacement of the halogen by an N-substituted amine; libraries |
| 08/22/2002 | US20020115610 Isolated polypeptides that stimulate gastrointestinal smooth muscle contraction, including human; ionotropic agents; enhanced gastrointestinal motility; identifying a prokineticin receptor ligand; calcium mobilization |
| 08/22/2002 | US20020115609 Materials and methods for making improved micelle compositions |
| 08/22/2002 | US20020115608 Uses of transgenic animals containing a type X collagen mutant |
| 08/22/2002 | US20020115607 Involved in the pathogenesis of Huntington's Disease, Parkinson's Disease, dementia and Alzheimer's Disease (AD); diagnosis, drug screening, animal models |
| 08/22/2002 | US20020115605 Novel peptide with effects on cerebral health |
| 08/22/2002 | US20020115604 HCaRG, a novel calcium-regulated gene coding for a nuclear protein |
| 08/22/2002 | US20020115603 Methods and compositions for the treatment of peripheral artery disease |
| 08/22/2002 | US20020115602 Human beta-defensin-3 (HBD-3), a highly cationic beta-defensin antimicrobial peptide |
| 08/22/2002 | US20020115601 Methods of increasing lean tissue mass using OB protein compositions |
| 08/22/2002 | US20020115600 Inhibitors of memapsin 2 and use thereof |
| 08/22/2002 | US20020115599 Nucleic acid of given sequence; protein involved in mechanisms during mitosis |
| 08/22/2002 | US20020115598 Method for the improvement of neuronal regeneration |
| 08/22/2002 | US20020115597 Antibiotics GE 23077, pharmaceutically acceptable salts and compositions, and use thereof |
| 08/22/2002 | US20020115595 Bioactive agent is covalently conjugated to an organocobalt complex's cobalt atom through a non-reactive atom in the bioactive agent molecule such as peptide, protein, nucleic acid and analogues |
| 08/22/2002 | US20020115594 Peptide antagonists at glutamate and NMDA receptors |
| 08/22/2002 | US20020115592 And optionally aprotinin, in a nonaqueous hydrophilic medium of an alcohol and a cosolvent, in association with a medium chain partial glyceride, optionally in admixture a long-chain polyoxyethylene glycol; fine suspension |
| 08/22/2002 | US20020115591 Gene yneS found in Streptococcus pneumoniae, which is essential for survival for a wide range of bacteria; use to identify antibiotics |
| 08/22/2002 | US20020115590 For subcutaneous, intramuscular or intradermal administration of coagulation factor VIIa (FVIIa) |
| 08/22/2002 | US20020115589 Use of inhibitors of TGF-beta's functions to ameliorate ocular pathology |
| 08/22/2002 | US20020115588 Dry powder of parathyroid hormone suitable for inhalation of specified particle size in diameters; treating osteoporosis |
| 08/22/2002 | US20020115214 Induction of lymphocytes; obtain cells, activate cells, incubate with activator, monitor lymphocyte proliferation |
| 08/22/2002 | US20020115213 Engraftable neural progenitor & stem cells for brain tumor therapy |
| 08/22/2002 | US20020115211 In vitro fertilization of human oocytes; obtain cells, incubate in nutrient broths, feterlize cells, propagate |
| 08/22/2002 | US20020115207 Methods and compositions for use in spliceosome mediated RNA trans-splicing |
| 08/22/2002 | US20020115206 Established cell line of microglia |
| 08/22/2002 | US20020115191 KdtB |
| 08/22/2002 | US20020115187 Nucleotide sequences coding enzymatic polypeptide for use in the treatment of arthritis and cancer; for use as antiscarring agent |
| 08/22/2002 | US20020115185 Nucleotide sequences coding preferential polypeptides for use in the treatment of cancer, nervous system, immunological, autoimmune disorders |
| 08/22/2002 | US20020115184 Antibiotic protein and method of production |
| 08/22/2002 | US20020115183 Enzymatic protien for us ein prevention of tumor metastasis |
| 08/22/2002 | US20020115177 Regulation of human histone deacetylase |
| 08/22/2002 | US20020115176 Polypeptide for use in the diagnosis and treatment of asthma, and respiratory disorders |
| 08/22/2002 | US20020115173 Short peptides from the 'A-region' of protein kinases which selectively modulate protein kinase activity |
| 08/22/2002 | US20020115172 Polypeptides for use in the diagnosis, prevention, and treatment of inflammation, cell proliferation and apoptosis disorders |
| 08/22/2002 | US20020115167 Isolation of drosophila and human polynucleotides encoding PAR-1 kinase, polypeptides encoded by the polynucleotides and methods utilizing the polynucleotides and polypeptides |
| 08/22/2002 | US20020115166 Peptide for use in the treatment of pancreatic defects |
| 08/22/2002 | US20020115156 Connective tissue growth factor for use in the treatment of cancer, fibrotic defects and atherosclerosis; for use as wound healing agents |
| 08/22/2002 | US20020115155 Nucleotide sequences coding polypeptide for use in the treatment and diagnosis of eating disorders |
| 08/22/2002 | US20020115152 Expression system for factor VIII |
| 08/22/2002 | US20020115151 Human defensin polypeptide Def-X, genomic DNA and cDNA, composition containing them and applications to diagnosis and to therapeutic treatment |
| 08/22/2002 | US20020115150 Polypeptide for use in the treatment and diagnosis of vision defects and diabetes |
| 08/22/2002 | US20020115145 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 08/22/2002 | US20020115144 Nucleotide sequences coding protein for use in the diagnosis and treatment of intracellular vessicle defects |
| 08/22/2002 | US20020115143 Expression vector coding immunoglobulin for use in the of infections and cancer |
| 08/22/2002 | US20020115140 Nucleotide sequences coding preferential polypeptide for use in treatment of immmunological defects |
| 08/22/2002 | US20020115138 Nucleotide sequences coding transport protein for use in treat ment of tumors |
| 08/22/2002 | US20020115135 Synapse related glycoproteins |
| 08/22/2002 | US20020115133 Cyclic lipopeptide acylase |
| 08/22/2002 | US20020115119 Protein-protein interactions in neurodegenerative diseases |
| 08/22/2002 | US20020115112 Neutrokine-alpha and Neutrokine-alpha splice variant |
| 08/22/2002 | US20020115109 Compositions and methods for diagnosing/treating disease based on beta-catenin/transcription factor interactions |
| 08/22/2002 | US20020115104 Detecting antitumor agent; obtain wildtype and mutant proteins, incubate, exposue to modulator, evaluate preferential gene activity |
| 08/22/2002 | US20020115103 Copolymer 1 related polypeptides for use as molecular weight markers and for therapeutic use |
| 08/22/2002 | US20020115102 Novel protein |
| 08/22/2002 | US20020115087 Detecting respiratory disorder; obtain tissue sample, determine nucleotide sequence, incubate with probes, determine genotype, evaluate for genetic disorders |
| 08/22/2002 | US20020115081 Nucleotide sequences coding polypeptide for use in the the treatament of cardiovasculAR disorders |
| 08/22/2002 | US20020115078 Nucleotide sequences coding polypeptide for use in the treatment and prevention of bacterial infections |
| 08/22/2002 | US20020115075 Polypeptide for use in screening bactericides |
| 08/22/2002 | US20020115069 Nucleotide sequences coding preferential polypeptide for use in diagnosis and treatment of osteoporosis, gastrointestinal disorders, hepatitis and tumors |
| 08/22/2002 | US20020115066 Detecting modulators which prevent viral infection; obtain lipid globule targeting sequence, incubate with modulator and globule, monitor adjustment in globule and binding protein activity |
| 08/22/2002 | US20020115064 Peptide or protein for use in the diagnosis, treatment or prophylaxis of viral disease |
| 08/22/2002 | US20020115061 Peptides for inducing cytotoxic t lymphocyte responses to hepatitis c viris |
| 08/22/2002 | US20020115058 Methods for diagnosis and treatment of diseases associated with altered expression of Pik3r1 |
| 08/22/2002 | US20020114848 Methods for regulating levels of zinc, cadmium and calcium in humans and for diagnosing, or screening for the risk of developing, diseases associated with abnormal levels of cadmium, zinc and calcium in body fluids and tissues |
| 08/22/2002 | US20020114845 Methods for processing animal tissues |
| 08/22/2002 | US20020114829 Therapy of autism, multiple sclerosis, eneuresis, Parkinson's disease, amyotrophic lateral sclerosis, brain ischemia, stroke, Cerebral palsy, sleep disorder, feeding disorder and AIDS-associated dementias, using biologically active liposome |
| 08/22/2002 | US20020114816 Autoreactive peptides from human glutamic acid-decarboxylase (gad) |
| 08/22/2002 | US20020114814 CTLA4-Cgamma4 fusion proteins |
| 08/22/2002 | US20020114811 Contacting body fluid from mammal with antibody which binds to human aspartyl (asparaginyl) beta-hydroxylase (HAAH) polypeptide under conditions sufficient to form antigen-antibody complex and detecting complex |
| 08/22/2002 | US20020114810 Diagnosis and treatment of malignant neoplasms statement as to federally sponsored research |
| 08/22/2002 | US20020114805 Methods of treating myelodysplastic syndrome with anti-TNF antibodies |
| 08/22/2002 | US20020114804 Administering agent capable of inhibiting signalling mediated by beta 1 integrin cell surface receptor of leukocyte cells in amount effective to enhance migration of leukocyte cells into fibrin to reach and kill bacteria |
| 08/22/2002 | US20020114803 Compositions and methods for enhancing receptor-mediated cellular internalization |
| 08/22/2002 | US20020114801 Heparanase specific molecular probes and their use in research and medical applications |
| 08/22/2002 | US20020114799 Protein-protein interactions in neurodegenerative diseases |
| 08/22/2002 | US20020114798 Stable enzymatic wound debrider |
| 08/22/2002 | US20020114797 Composition and methods for modulating the length of telomeres |
| 08/22/2002 | US20020114796 Wound healing agents comprising fibrinogen, fibrin, thrombin, transglutaminase, and serpin protease inhibitor which doesn not inhibit collagenase and elastase in blood plasma |
| 08/22/2002 | US20020114795 Composition and process for bone growth and repair |
| 08/22/2002 | US20020114792 Alpha-2-macroglobulin therapies and drug screening methods for Alzheimer's disease |
| 08/22/2002 | US20020114789 Methods of controlling proliferation and differentiation of stem and progenitor cells |
| 08/22/2002 | US20020114787 Tolerance to natural antibody antigens |
| 08/22/2002 | US20020114782 Stabilized interferon compositions |
| 08/22/2002 | US20020114781 Interleukin antagonists for suppressing autoimmune respone via reducing number of antigen-reactive lymphocytes; treatment of rheumatic diseases |
| 08/22/2002 | US20020114780 Methods of increasing distribution of therapeutic agents |
| 08/22/2002 | US20020114779 Osteoclast secreted chemokine and uses thereof |
| 08/22/2002 | US20020114772 Methods of modulating hair growth |
| 08/22/2002 | DE10108212A1 Fusionsprotein zur Sekretion von Wertprotein in bakterielle Überstände Fusion protein for secretion of value protein in bacterial supernatants |
| 08/22/2002 | DE10100238A1 Verfahren zur Vorhersage des Gefährdungspotentials für Karzinomerkrankungen und entzündliche Darmerkrankungen und zugehörige Tests A method for predicting the risk potential for cancer diseases and inflammatory bowel disease and related tests |
| 08/22/2002 | DE10100053A1 Verwendung von Enzyminhibitoren der Dipeptidylpeptidase IV sowie der Aminopeptidase N und pharmazeutischen Zubereitungen daraus zur Prävention und/oder Therapie Ischämie-bedingter akuter und chronischer neurodegenerativer Prozesse und Erkrankungen Use of enzyme inhibitors of the dipeptidyl peptidase IV as well as the aminopeptidase N and pharmaceutical preparations thereof for the prevention and / or therapy of ischemia-related acute and chronic neurodegenerative diseases and processes |
| 08/22/2002 | DE10055857A1 Neue pharmazeutische Depotformulierung New pharmaceutical depot formulation |
| 08/22/2002 | CA2854685A1 Optimized messenger rna |
| 08/22/2002 | CA2440743A1 Matrix gene expression in chondrogenesis |